MOXIDECTIN Drug Patent Profile
✉ Email this page to a colleague
When do Moxidectin patents expire, and what generic alternatives are available?
Moxidectin is a drug marketed by Mdgh and is included in one NDA.
The generic ingredient in MOXIDECTIN is moxidectin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the moxidectin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Moxidectin
A generic version of MOXIDECTIN was approved as moxidectin by MDGH on June 13th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MOXIDECTIN?
- What are the global sales for MOXIDECTIN?
- What is Average Wholesale Price for MOXIDECTIN?
Summary for MOXIDECTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Clinical Trials: | 22 |
| Patent Applications: | 3,194 |
| What excipients (inactive ingredients) are in MOXIDECTIN? | MOXIDECTIN excipients list |
| DailyMed Link: | MOXIDECTIN at DailyMed |
Recent Clinical Trials for MOXIDECTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Public Health Laboratory Ivo de Carneri | Phase 3 |
| Washington University School of Medicine | Phase 2 |
| National Public Health Institute of Liberia | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for MOXIDECTIN
US Patents and Regulatory Information for MOXIDECTIN
MOXIDECTIN is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting MOXIDECTIN
INDICATED FOR THE TREATMENT OF ONCHOCERCIASIS DUE TO ONCHOCERCA VOLVULUS IN PATIENTS AGED 12 YEARS AND OLDER
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mdgh | MOXIDECTIN | moxidectin | TABLET;ORAL | 210867-001 | Jun 13, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
